Cargando…
High expression of aurora kinase B predicts poor prognosis in hepatocellular carcinoma after curative surgery and its effects on the tumor microenvironment
BACKGROUND: Currently, the only broadly used biomarker for hepatocellular carcinoma (HCC), alpha fetoprotein (AFP), has multiple limitations and the need for novel biomarkers is urgent. Aurora kinase B (AURKB) is a key mitotic protein kinase which performs a critical function in cell cycle progressi...
Autores principales: | Zhao, Huan, Wang, Yu, Yang, Zhishi, Wei, Wenxin, Cong, Zhuangzhi, Xie, Yanting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708486/ https://www.ncbi.nlm.nih.gov/pubmed/36467342 http://dx.doi.org/10.21037/atm-22-4798 |
Ejemplares similares
-
DNA hypermethylation of aurora kinase A in hepatitis C virus-positive hepatocellular carcinoma
por: Ma, Zuohong, et al.
Publicado: (2019) -
An independent poor-prognosis subtype of hepatocellular carcinoma based on the tumor microenvironment
por: Wang, Junfeng, et al.
Publicado: (2021) -
High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2020) -
Targeting high Aurora kinases expression as an innovative therapy for hepatocellular carcinoma
por: Liu, Fuchen, et al.
Publicado: (2017) -
Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
por: Goos, J A C M, et al.
Publicado: (2013)